ArticleImmunoTargets and therapy2026

A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted Immunotherapy.

Yuxin Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.